This document provides information on the inventory and capabilities of BBI Biobank, a company that collects and sells clinical samples and disease state plasma. It lists various plasma and serum products available for diseases like infectious diseases (HIV, HCV, HBV), autoimmune/non-infectious diseases (anti-GBM, CRP), and depleted serum products. It also describes the company's custom sample collection and depletion services. Key capabilities highlighted include direct collection from blood banks and hospitals, comprehensive characterization of samples, and operating under ISO standards.
Disease State Plasma Newsflash - August 2014 - BBI SolutionsBBISolutions
In this month’s newsflash view our latest inventory of autoimmune, infectious disease and ethically approved disease state plasma units. You can also find out about our ethics approval scheme and our speciality blood products.
Antibodies Newsflash - September 2014 - BBI SolutionsBBISolutions
In this month’s newsflash you can see the new range of veterinary antibodies available from BBI Solutions along with new analysis data for ST2 antibodies and CRP antibodies.
April 2014 - Antibodies Newsflash - BBI SolutionsBBISolutions
This month’s newsflash focuses on our recombinant Fab antibodies. Find out more about their clinical relevance and see new performance data for Cystatin C, Myeloperoxidase and C Reactive Protein recombinant Fab antibodies.
September 2015 - Antibodies Newsflash - BBI SolutionsBBISolutions
Find out about our newly developed CEA antibody pairings in this month's Antibodies newsflash as well as new data on HIV p24 and Vancomycin A Monoclonals.
April 2015 - Disease State Plasma Newsflash - BBI SolutionsBBISolutions
In this newsflash find out about our Disease State Plasma range and be one of the first to learn about our exciting new product launch of Clinical Specimen Panels coming soon to the BBI Solutions product portfolio.
A brief introduction to the range of human proteins available from BBI Solutions and our custom protein analysis, development and manufacturing services.
Disease State Plasma Newsflash - August 2014 - BBI SolutionsBBISolutions
In this month’s newsflash view our latest inventory of autoimmune, infectious disease and ethically approved disease state plasma units. You can also find out about our ethics approval scheme and our speciality blood products.
Antibodies Newsflash - September 2014 - BBI SolutionsBBISolutions
In this month’s newsflash you can see the new range of veterinary antibodies available from BBI Solutions along with new analysis data for ST2 antibodies and CRP antibodies.
April 2014 - Antibodies Newsflash - BBI SolutionsBBISolutions
This month’s newsflash focuses on our recombinant Fab antibodies. Find out more about their clinical relevance and see new performance data for Cystatin C, Myeloperoxidase and C Reactive Protein recombinant Fab antibodies.
September 2015 - Antibodies Newsflash - BBI SolutionsBBISolutions
Find out about our newly developed CEA antibody pairings in this month's Antibodies newsflash as well as new data on HIV p24 and Vancomycin A Monoclonals.
April 2015 - Disease State Plasma Newsflash - BBI SolutionsBBISolutions
In this newsflash find out about our Disease State Plasma range and be one of the first to learn about our exciting new product launch of Clinical Specimen Panels coming soon to the BBI Solutions product portfolio.
A brief introduction to the range of human proteins available from BBI Solutions and our custom protein analysis, development and manufacturing services.
BBI is a leading supplier of enzymes for diagnostic and research applications. They have over 50 years of experience producing high-quality enzymes. Some of their key products mentioned in the document include glucose oxidase, glucose dehydrogenase, alkaline phosphatase, and horseradish peroxidase. The document provides details on the performance, quality control, and benefits of these enzymes. It emphasizes BBI's long experience producing enzymes like chymotrypsin and trypsin, with consistent high quality and batch-to-batch reproducibility.
This newsletter from BBI Solutions announces new products including Ebola antibodies suitable for rapid tests and a range of veterinary antibodies. It highlights antibody data showing strong binding affinities for recombinant Fab antibodies against Cystatin C and S100 Beta. The document promotes BBI's capabilities in monoclonal antibodies, polyclonal antibodies, and recombinant Fab antibodies targeting various diseases and conditions. It provides information on ordering antibodies and links to individual product pages.
05 elisa kits for eyelid basal cell carcinoma researchElabscience
Eyelid basal cell carcinoma is the most common malignant tumor of the
eyelids, and the tumor was differentiated from epidermal basal cells.
The most important risk factor is ultraviolet light.More info visit:
http://www.elabscience.com
Learn about a powerful new cell-based assay for specifically measuring target cancer cell death in co-cultures. Very useful in the development of immunotherapy drugs.
May 2015 Antibodies Newsflash - BBI SolutionsBBISolutions
This month's Antibodies Newsflash features CRP recombinant FAB antibodies, D-Dimer and HbA1c monoclonal antibodies plus more.
Click through the slides to find out what makes these leading products in BBI's antibodies range.
The KILRTM cytotoxicity assay specifically measures target cell death in co-cultures. It provides an easy-to-use and sensitive method to determine target cell death with chemiluminescent readout. The assay has broad applications in developing cancer immunotherapies like ADCC, ADCP, CAR-T, and bi-specific antibody therapies. It offers high specificity, sensitivity, flexibility and reproducibility compared to other cytotoxicity assays.
01 elisa kits for malignant ascites researchElabscience
The document lists various ELISA kits for detecting levels of proteins involved in cancer. For each kit, it provides the product code, protein name being detected, detection range, sensitivity, and test method. The kits use ELISA (enzyme-linked immunosorbent assay) to detect proteins including TP53, CDKN2A, KRAS, EGFR, CCND1, VEGF-A, IL-6, PDGFRβ, ALB, BRAF, JAK2, ERα, MMP-2, BRCA2, TM, MMP-9, and BRCA1 within certain concentration ranges with good sensitivity. All kits employ a sandwich ELISA test method.
24 elisa kits for carcinoma of penis researchElabscience
Carcinoma of penis, also called penile cancer, is a malignant growth found on the skin or in the tissues of the penis. Around 95% of penile cancers are squamous cell carcinomas. Other types of penile cancer such as Merkel cell carcinoma, small cell carcinoma, melanoma and other are generally rare.Symptoms include redness of the penis, rash on the penis, foul smelling discharge from the penis and pain in the penis, etc. More info visit: http://www.elabscience.com
02 elisa kits for malignant pleural effusion researchElabscience
Malignant pleural effusion is a condition in which cancer causes an
abnormal amount of fluid to collect between the thin layers of tissue
(pleura) lining the outside of the lung and the wall of the chest
cavity. Lung cancer and breast cancer account for about 50-65% of
malignant pleural effusions. Other common causes include pleural
mesothelioma and lymphoma.More info visit: http://www.elabscience.com
This document provides information about antibody validation reviews from St. John's Laboratory. It details their process for scientists to receive free samples of antibodies and submit independent reviews. Reviews provide experimental results for specific antibodies used for techniques like western blot, immunohistochemistry, and immunofluorescence on various cell lines and tissues. Overall, the reviews demonstrate that the antibodies generated the expected target bands or labeling across different validation experiments.
52 elisa kits for nasopharynx cancer researchElabscience
Nasopharynx cancer or nasopharyngeal carcinoma (NPC) is the most common cancer originating in the nasopharynx, the uppermost region of the pharynx ("throat"), behind the nose where thenasal passages and auditory tubes join the remainder of the upper respiratory tract. Nasopharyngeal carcinoma (NPC) is caused by a combination of factors: viral, environmental influences, and heredity.More info visit: http://www.elabscience.com
PBL Assay Science is a biotechnology company that has worked for over 24 years to develop assays and proteins to help researchers solve difficult protein quantification problems. The company was founded in 1990 and has 35 employees based in New Jersey. It produces ELISA and multiplex assay kits, recombinant proteins, antibodies, and provides custom assay services, with a focus on interferons and cytokines.
09 elisa kits for hemangioma of bone researchElabscience
Hemagioma can occurs in all parts of the body, and it may also occurs
in bone, but the latter is more rare than the others parts of body.
Hemangioma of bone sometimes exists with hemangioma of other parts at
the same time, it is a common tumor of benign tumor attached in bone
tissue.More info visit: http://www.elabscience.com
04..elisa kits for peyronie disease researchElabscience
Prostatitis is inflammation of the prostate gland. Prostatitis is classified into acute, chronic, asymptomatic inflammatory prostatitis, and chronic pelvic pain syndrome. Acute prostatitis is a bacterial infection of the prostate gland that requires urgent medical treatment. Chronic prostatitis is a pelvic paincondition in men, formerly known as prostatodynia (painful prostate).More info visit: http://www.elabscience.com
02.elisa kits for congenital cataract researchElabscience
The document lists 11 ELISA kits for detecting various human proteins including Crystallin Alpha B, EphA2, Collagen Type II Alpha 1, Vimentin, Transglutaminase 1, Cytochrome P450 1B1, Ferritin Light Polypeptide, Forkhead Box Protein C1, Actin Alpha 1, Transferrin, and Congenital Cataract. For each kit it provides the product number, product name, detection range, sensitivity, and test method which is sandwich ELISA for all kits.
This document discusses cancer at multiple levels. It begins by explaining that cancer starts when cells divide uncontrollably and spread into surrounding tissues. There are over 100 types of cancer named for the organs or tissues where they form. Later sections provide more details on genetic and molecular factors that drive cancer, including changes to proto-oncogenes, tumor suppressor genes, and DNA repair genes. The document also describes tumor markers and their role in cancer detection, diagnosis and prognosis. It concludes by listing ELISA kits from Elabscience focused on targets relevant to cancer research.
Answer four fundamental questions on how to develop the most innovative cancer immunotherapy treatments, starting with screening for lead molecules and ending with evaluation of combination therapies.
Presentation of David Rimm in 1st International Antibody Validation Forum 2014St John's Laboratory Ltd
Dr. David Rimm is a Professor in the Department of Pathology at the Yale University School of Medicine. He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and a Cytopathology Fellowship at the Medical College of Virginia. Dr. Rimm is the Director of Translational Pathology and the Director of Yale Pathology Tissue Services. His lab group (15 researchers) focuses on quantitative pathology using the AQUA® technology invented in his lab with projects related to predicting response to therapy in breast and lung cancer and predicting recurrence or metastasis in breast and lung cancer. The technology has also been used in a series of efforts related to biospecimen science. He also has a group working on primary tumor culture using the conditionally reprogrammed cell method. He is a member of a number of correlative science committees for multi-institutional breast cancer clinical trials including SWOG, ALLTO, and TEACH. He also serves on the Molecular Oncology committee for the College of American Pathologists (CAP). He is currently supported by grants from both public and private sources. He is an author of over 280 peer-reviewed papers and 8 patents. He has served on advisory boards for Genentech, Novaritis, BMS, Perkin Elmer, Dako, ACD, Avida and Genoptix. He was a scientific co-founder of HistoRx, a digital pathology company (sold to Genoptix in 2012) and Metamark Genetics, a prognostic determinant company.
For more details about 1st international antibody validation forum please check on http://www.stjohnslabs.com/ac_cms/blog
Multi-domain Challenges of Fc Fusion Proteins and Bispecific AntibodiesJin Di, Ph.D.
This document does not contain enough content to summarize. It only contains the word "Multi" with no other context or details provided. Therefore, a meaningful summary cannot be generated from the limited information given.
Shanghai Caerulum Pharma Discovery Co., Ltd. is a chemical service company established in 2012 to assist customers in drug discovery and development. They have 4 standard laboratories, 3 pilot laboratories, and access to larger cooperating factories. Their team includes 18 chemists and experts in various roles. They provide customized synthesis, process research and development, and quality control. Their strengths include strict confidentiality, quick communication, safety controls, and detailed documentation to support drug applications. They focus on areas like diabetes, cancer, and inflammation.
The document discusses StatLab's new line of immunohistochemistry (IHC) reagents, including ready-to-use antibodies for various markers in pre-diluted formats of 6mL or 10mL. It provides a table listing over 100 monoclonal and polyclonal antibody options across various species and clones. The document promotes StatLab IHC reagents as delivering high quality staining at an economical cost for pathologists and histotechnologists.
BBI is a leading supplier of enzymes for diagnostic and research applications. They have over 50 years of experience producing high-quality enzymes. Some of their key products mentioned in the document include glucose oxidase, glucose dehydrogenase, alkaline phosphatase, and horseradish peroxidase. The document provides details on the performance, quality control, and benefits of these enzymes. It emphasizes BBI's long experience producing enzymes like chymotrypsin and trypsin, with consistent high quality and batch-to-batch reproducibility.
This newsletter from BBI Solutions announces new products including Ebola antibodies suitable for rapid tests and a range of veterinary antibodies. It highlights antibody data showing strong binding affinities for recombinant Fab antibodies against Cystatin C and S100 Beta. The document promotes BBI's capabilities in monoclonal antibodies, polyclonal antibodies, and recombinant Fab antibodies targeting various diseases and conditions. It provides information on ordering antibodies and links to individual product pages.
05 elisa kits for eyelid basal cell carcinoma researchElabscience
Eyelid basal cell carcinoma is the most common malignant tumor of the
eyelids, and the tumor was differentiated from epidermal basal cells.
The most important risk factor is ultraviolet light.More info visit:
http://www.elabscience.com
Learn about a powerful new cell-based assay for specifically measuring target cancer cell death in co-cultures. Very useful in the development of immunotherapy drugs.
May 2015 Antibodies Newsflash - BBI SolutionsBBISolutions
This month's Antibodies Newsflash features CRP recombinant FAB antibodies, D-Dimer and HbA1c monoclonal antibodies plus more.
Click through the slides to find out what makes these leading products in BBI's antibodies range.
The KILRTM cytotoxicity assay specifically measures target cell death in co-cultures. It provides an easy-to-use and sensitive method to determine target cell death with chemiluminescent readout. The assay has broad applications in developing cancer immunotherapies like ADCC, ADCP, CAR-T, and bi-specific antibody therapies. It offers high specificity, sensitivity, flexibility and reproducibility compared to other cytotoxicity assays.
01 elisa kits for malignant ascites researchElabscience
The document lists various ELISA kits for detecting levels of proteins involved in cancer. For each kit, it provides the product code, protein name being detected, detection range, sensitivity, and test method. The kits use ELISA (enzyme-linked immunosorbent assay) to detect proteins including TP53, CDKN2A, KRAS, EGFR, CCND1, VEGF-A, IL-6, PDGFRβ, ALB, BRAF, JAK2, ERα, MMP-2, BRCA2, TM, MMP-9, and BRCA1 within certain concentration ranges with good sensitivity. All kits employ a sandwich ELISA test method.
24 elisa kits for carcinoma of penis researchElabscience
Carcinoma of penis, also called penile cancer, is a malignant growth found on the skin or in the tissues of the penis. Around 95% of penile cancers are squamous cell carcinomas. Other types of penile cancer such as Merkel cell carcinoma, small cell carcinoma, melanoma and other are generally rare.Symptoms include redness of the penis, rash on the penis, foul smelling discharge from the penis and pain in the penis, etc. More info visit: http://www.elabscience.com
02 elisa kits for malignant pleural effusion researchElabscience
Malignant pleural effusion is a condition in which cancer causes an
abnormal amount of fluid to collect between the thin layers of tissue
(pleura) lining the outside of the lung and the wall of the chest
cavity. Lung cancer and breast cancer account for about 50-65% of
malignant pleural effusions. Other common causes include pleural
mesothelioma and lymphoma.More info visit: http://www.elabscience.com
This document provides information about antibody validation reviews from St. John's Laboratory. It details their process for scientists to receive free samples of antibodies and submit independent reviews. Reviews provide experimental results for specific antibodies used for techniques like western blot, immunohistochemistry, and immunofluorescence on various cell lines and tissues. Overall, the reviews demonstrate that the antibodies generated the expected target bands or labeling across different validation experiments.
52 elisa kits for nasopharynx cancer researchElabscience
Nasopharynx cancer or nasopharyngeal carcinoma (NPC) is the most common cancer originating in the nasopharynx, the uppermost region of the pharynx ("throat"), behind the nose where thenasal passages and auditory tubes join the remainder of the upper respiratory tract. Nasopharyngeal carcinoma (NPC) is caused by a combination of factors: viral, environmental influences, and heredity.More info visit: http://www.elabscience.com
PBL Assay Science is a biotechnology company that has worked for over 24 years to develop assays and proteins to help researchers solve difficult protein quantification problems. The company was founded in 1990 and has 35 employees based in New Jersey. It produces ELISA and multiplex assay kits, recombinant proteins, antibodies, and provides custom assay services, with a focus on interferons and cytokines.
09 elisa kits for hemangioma of bone researchElabscience
Hemagioma can occurs in all parts of the body, and it may also occurs
in bone, but the latter is more rare than the others parts of body.
Hemangioma of bone sometimes exists with hemangioma of other parts at
the same time, it is a common tumor of benign tumor attached in bone
tissue.More info visit: http://www.elabscience.com
04..elisa kits for peyronie disease researchElabscience
Prostatitis is inflammation of the prostate gland. Prostatitis is classified into acute, chronic, asymptomatic inflammatory prostatitis, and chronic pelvic pain syndrome. Acute prostatitis is a bacterial infection of the prostate gland that requires urgent medical treatment. Chronic prostatitis is a pelvic paincondition in men, formerly known as prostatodynia (painful prostate).More info visit: http://www.elabscience.com
02.elisa kits for congenital cataract researchElabscience
The document lists 11 ELISA kits for detecting various human proteins including Crystallin Alpha B, EphA2, Collagen Type II Alpha 1, Vimentin, Transglutaminase 1, Cytochrome P450 1B1, Ferritin Light Polypeptide, Forkhead Box Protein C1, Actin Alpha 1, Transferrin, and Congenital Cataract. For each kit it provides the product number, product name, detection range, sensitivity, and test method which is sandwich ELISA for all kits.
This document discusses cancer at multiple levels. It begins by explaining that cancer starts when cells divide uncontrollably and spread into surrounding tissues. There are over 100 types of cancer named for the organs or tissues where they form. Later sections provide more details on genetic and molecular factors that drive cancer, including changes to proto-oncogenes, tumor suppressor genes, and DNA repair genes. The document also describes tumor markers and their role in cancer detection, diagnosis and prognosis. It concludes by listing ELISA kits from Elabscience focused on targets relevant to cancer research.
Answer four fundamental questions on how to develop the most innovative cancer immunotherapy treatments, starting with screening for lead molecules and ending with evaluation of combination therapies.
Presentation of David Rimm in 1st International Antibody Validation Forum 2014St John's Laboratory Ltd
Dr. David Rimm is a Professor in the Department of Pathology at the Yale University School of Medicine. He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and a Cytopathology Fellowship at the Medical College of Virginia. Dr. Rimm is the Director of Translational Pathology and the Director of Yale Pathology Tissue Services. His lab group (15 researchers) focuses on quantitative pathology using the AQUA® technology invented in his lab with projects related to predicting response to therapy in breast and lung cancer and predicting recurrence or metastasis in breast and lung cancer. The technology has also been used in a series of efforts related to biospecimen science. He also has a group working on primary tumor culture using the conditionally reprogrammed cell method. He is a member of a number of correlative science committees for multi-institutional breast cancer clinical trials including SWOG, ALLTO, and TEACH. He also serves on the Molecular Oncology committee for the College of American Pathologists (CAP). He is currently supported by grants from both public and private sources. He is an author of over 280 peer-reviewed papers and 8 patents. He has served on advisory boards for Genentech, Novaritis, BMS, Perkin Elmer, Dako, ACD, Avida and Genoptix. He was a scientific co-founder of HistoRx, a digital pathology company (sold to Genoptix in 2012) and Metamark Genetics, a prognostic determinant company.
For more details about 1st international antibody validation forum please check on http://www.stjohnslabs.com/ac_cms/blog
Multi-domain Challenges of Fc Fusion Proteins and Bispecific AntibodiesJin Di, Ph.D.
This document does not contain enough content to summarize. It only contains the word "Multi" with no other context or details provided. Therefore, a meaningful summary cannot be generated from the limited information given.
Shanghai Caerulum Pharma Discovery Co., Ltd. is a chemical service company established in 2012 to assist customers in drug discovery and development. They have 4 standard laboratories, 3 pilot laboratories, and access to larger cooperating factories. Their team includes 18 chemists and experts in various roles. They provide customized synthesis, process research and development, and quality control. Their strengths include strict confidentiality, quick communication, safety controls, and detailed documentation to support drug applications. They focus on areas like diabetes, cancer, and inflammation.
The document discusses StatLab's new line of immunohistochemistry (IHC) reagents, including ready-to-use antibodies for various markers in pre-diluted formats of 6mL or 10mL. It provides a table listing over 100 monoclonal and polyclonal antibody options across various species and clones. The document promotes StatLab IHC reagents as delivering high quality staining at an economical cost for pathologists and histotechnologists.
AbMole BioScience is a rapidly growing, professional inhibitors supplier. AbMole provide high purity life science reagents such as kinase inhibitors for laboratory research. AbMole have unique collection of over 2000 inhibitors on HDAC, PI3K, Apoptosis and more signaling pathways in stock.
This report provides an analysis of the product pipeline of Wave 80 Biosciences, Inc., a company focused on developing molecular diagnostics instruments and assays for conditions like hepatitis C, hepatitis B, HIV/AIDS, and others. The report details each of the company's pipeline products, including their indication, development stage, milestones, and technology. Key products in Wave 80's pipeline include quantitative assays for measuring viral loads of HIV, HBV, and HCV, as well as assays for tuberculosis, sexually transmitted diseases, and various protein biomarkers. The company utilizes its proprietary EOSCAPE molecular diagnostics technology. The report provides information on Wave 80's facilities, competitors, employees, and an overview of the molecular diagnostics market. It
Transports 1 Ca2+ and 1 K+ in exchange for 4 Na+. Controls the rapid response termination and proper regulation of adaptation in olfactory sensory neurons (OSNs) which subsequently influences how odor information is encoded and perceived. May play a role in calcium transport during amelogenesis.
To purchase this antibody, use the following link: http://www.stjohnslabs.com/nckx4-antibody?filter_name=STJ94359
This document outlines the ADCC (antibody-dependent cell-mediated cytotoxicity) assay market. It notes that biologics such as monoclonal antibodies will make up 7 of the top 10 pharmaceuticals by 2016. There are currently over 500 monoclonal antibodies and 900 biosimilars/biobetters in development globally. ADCC assays are required by regulatory agencies to characterize biologics and are used throughout the development and manufacturing process. The document predicts the ADCC assay market size to be over $150 million in Korea and China alone by 2015 based on the large biologics pipeline and manufacturing volume in those regions. It concludes by providing contact information for ADCC assay services.
This document provides an overview of Advanced Preservation Technologies, LLC, a new technology development company. It describes two exclusive licenses the company has obtained - one from NASA for a preservative used in the space program, and one being negotiated from a major university for a biopolymer that preserves samples for extended periods of time. The document outlines current and potential applications of the technologies, including preserving urine, blood, and other samples without refrigeration. Financial projections through year 5 anticipate growing revenue from sales of urine and blood tubes as production and customers increase. Key leadership is introduced, along with their relevant experience.
The customer tested an NCKX3 polyclonal antibody from St John's Laboratory using western blot on HEK/MEB4/MNT-1 cells at a 1:1000 dilution. The testing results were positive and the customer stated they hoped to do more experiments using the antibody. St John's Laboratory invites customers to test their products risk-free by applying for free sample trials and submitting a review for 30% off a future order.
In this how to become expert in application X series, Boster Bio presents the comprehensive information for you to get a head start on the subject. In this case, you will learn everything you need to know to get started on IHC. You will learn how it works, how to choose the right antibody for IHC, which epitope retrieval method to choose, and many more.
Immunohistochemistry (IHC) is a method that combines biochemical, histological and immunological techniques into a simple but powerful assay for protein detection. IHC provides valuable information as it visualizes the distribution and localization of specific cellular components within cells and in proper tissue context.
IHC detects antigens or haptens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. The antibody-antigen binding can be visualized in different manners. Enzymes, such as Horseradish Peroxidase (HRP) or Alkaline Phosphatase (AP), are commonly used to catalyze a color-producing reaction. There are numerous IHC methods that can be used to localize antigens. The method selected should include consideration of parameters such as the specimen types and assay sensitivity.
This document provides guidance on how to perform immunohistochemistry (IHC) experiments in 4 days. It discusses key considerations for experimental design, including selecting the appropriate antibody type, target protein region, tissue fixation method, and includes sample protocols for IHC using paraffin sections, frozen sections, and cell climbing slices. The document also provides a troubleshooting guide and frequently asked questions section related to IHC.
This document summarizes information about Mercy Diagnostics laboratory. In 3 sentences:
Mercy Diagnostics aims to provide personalized service and support to medical providers by building local laboratories to guarantee quicker turnaround times and eliminate risks of lost samples, offering over 1300 tests designed around each practice's needs from their state-of-the-art analyzers requiring less blood. Their history began in 2012 when they were formed by industry professionals to oversee clinical laboratories and guarantee accurate, high-quality testing for healthcare providers in a timely manner.
This report provides an analysis of the product pipeline of LABiTec GmbH, a medical devices company focused on haemostasis and platelet-function diagnostics. It details the company's major products and services and analyzes its pipeline by equipment type and development stage. Key pipeline products profiled include the CoaLAB 1000 system for APTT, fibrinogen, and PT testing. The report aims to help readers develop business and market strategies by providing intelligence on LABiTec's technology landscape and competitive position. It provides detailed profiles of each pipeline product along with development status and clinical trial information where available.
Cybele is developing a Huntington's disease cell model using induced pluripotent stem cells to enable drug discovery. The team aims to create affected medium spiny neurons in vitro that can be used by academic researchers and pharmaceutical companies to identify potential drug targets and test compounds. Cybele is exploring commercializing purified cell populations for research or providing screening services using their cell model with partners. The company's goal is to accelerate Huntington's disease drug development and reduce costs by enabling earlier testing and failure of non-viable compounds.
The document summarizes Biotest's blood bank product offerings, including their traditional blood bank reagents and the Tango automated blood bank analyzer. It provides an overview of Biotest's history in transfusion diagnostics and leadership. Evaluation studies showed Biotest's rare antisera outperformed competitors' products in many cases. The Tango system offers flexibility, ease of use, and on-board reagent storage for up to seven days.
Bioclones is a South African company that manufactures biopharmaceuticals, including active pharmaceutical ingredients. It currently produces two biologics, Repotin (EPO) and G-CSF, to treat renal failure, cancer, and other diseases. However, South Africa imports most biologics and lacks domestic manufacturing capacity. Bioclones aims to develop South Africa's biotech industry but faces challenges in gaining support from the Department of Health and Treasury, which predominantly support multinational companies. Local production of biologics could create jobs, skills, economic growth, and ensure access and supply of important medicines.
Seventh Wave was established in 2003 and has grown from 5 to over 50 employees. It established a bioanalytical laboratory in 2006 to support drug discovery clients with LC-MS/MS analysis, method development and validation, pharmacokinetic studies, and in vitro assays. The bioanalytical lab has over 60 years of combined industry experience and state-of-the-art instrumentation to provide fast, high-quality service and respond to client challenges.
Seventh Wave was established in 2003 and has grown from 5 to over 50 employees. It established a bioanalytical laboratory in 2006 to support drug discovery clients with LC-MS/MS analysis, method development and validation, pharmacokinetic studies, and in vitro assays. The bioanalytical lab has over 60 years of combined industry experience and state-of-the-art instrumentation to provide fast, high-quality service and respond to client challenges.
This document provides instructions for performing a peptide radioimmunoassay (RIA). It describes the basic principles and components of the RIA kits including a radiolabeled tracer, standards, antiserum, and secondary antibodies. Detailed multi-day protocols are provided for setting up the assay, including reconstituting and diluting components, incubating samples and standards with antiserum and tracer, adding secondary antibodies and serum, and counting and analyzing results. Safety precautions are also described when handling radioactive materials.
A customer at Emory University tested an ELMOD2 polyclonal antibody from St. John's Laboratory at a 1:500 dilution in a Western blot protocol. They reported that the antibody could detect low levels (ng) of protein. St. John's Laboratory invites customers to test their products risk-free by applying for free trial samples online and then submitting a review to receive 30% off a future order.
Clinical Samples & Disease State Plasma Newsflash October 2016 finalBBISolutions
This document provides information on the inventory and capabilities of BBI Biobank, a company that collects and sells clinical samples and disease state plasma. It lists various plasma and serum products available for diseases like infectious diseases (HIV, HCV, HBV), autoimmune/non-infectious diseases (anti-GBM, CRP), and depleted serum products. It also describes the company's custom sample collection and depletion services. Key capabilities highlighted include direct collection from hospitals, comprehensive characterization of samples, and operating under ISO standards.
Overview of BBI Solutions products and technologies offered within nanoparticles development and manufacturing services, for the global diagnostic market.
This document summarizes the services provided by BBI Life Sciences for producing custom gold conjugates. BBI has over 25 years of experience performing over 500 conjugations per year for various applications. They offer reliable and reproducible conjugates produced at scale from small feasibility batches up to 24L. BBI works with customers to choose an appropriate target, particle size, and concentration for their specific needs and application. A full report is provided on the optimized conjugate's performance. Their services help customers avoid issues scaling up conjugates from development to production.
BBI Solutions is a leading provider of biological raw materials, antibodies, enzymes, and lateral flow development services to the diagnostics industry. For over 50 years, it has helped customers develop high-quality, sensitive assays. BBI has extensive expertise across its 500+ employees, ISO-certified facilities, and history of successfully completing over 250 lateral flow projects. It aims to be a long-term partner in helping customers develop innovative, regulated products and assays.
This newsletter from BBI Solutions announces new products including Ebola antibodies suitable for rapid tests and a range of veterinary antibodies. It highlights antibody data showing strong binding affinity for recombinant Fabs against Cystatin C and S100B. The document promotes BBI's monoclonal and polyclonal antibodies and recombinant Fab antibodies for various targets across key areas like infectious disease, cardiac, metabolic, and veterinary markets. It provides information on ordering antibodies and the company's capabilities.
Disease State Plasma Newsflash - January 2014 - BBI SolutionsBBISolutions
The BBI Solutions Disease State Plasma Newsflash gives details about our current inventory of disease state plasma, clinical samples and speciality blood products. This months features include our new autoimmune products and our rare infectious disease products.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Clinical Samples & Disease State Plasma Newsflash October 2016
1. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
11
Clinical Samples & Disease State Plasma
Current Biobank Inventory & Capabilities
* Although inventory information is correct on date of publishing, many of
the materials are in high demand and stocks are limited. Custom sample
collections are possible where published inventory items are already sold.
NEWS FLASH: October 2016
2. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
22
Contents
BBI Biobank – What makes our products stand out for the crowd? 3
New Products 4
Disease State Plasma Availability 5-8
Clinical Sample Availability 9-11
Depleted Serum 12-14
* Although inventory information is correct on date of publishing, many of
the materials are in high demand and stocks are limited. Custom sample
collections are possible where published inventory items are already sold.
3. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
3
BBI BIOBANK
What makes our products stand out from the
crowd?
Able to collect directly from Blood Banks and Hospitals
Comprehensive characterisation
Variety of materials available:
Early disease phase
Low, medium & high titres
Rare antibodies
Clinical data / donor demographics held for many units
IRB / Ethical approval status for most materials
Comprehensive and detailed CofA’s
Operate under ISO 13485 and ISO 9001
3
4. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
4
NEW PRODUCTS
NEW UNITS AVAILABLE NOW
HCV Plasma New Units
HBV/HCV Co-infected Units
C Reactive Protein Positive Plasma
Anti-Mitochondrial Antibodies Positive Plasma
Serum Amyloid A Positive Plasma
Glomerular Basement Membrane Antibodies Plasma
Bilirubin Positive Plasma
Lactate Dehydrogenase Positive Plasma
Acetylcholine Receptor Antibodies Positive Plasma
p-ANCA (MPO) Ab Positive Plasma
SITE UPDATES
Heat treatment now available for
Infectious Disease
Defibrination service available
HIV, HBV, HCV and Syphilis SCIPAC
mixed viral load and genotype sample
panels now available
COMING SOON
HIV-2 Serum Clinical Specimens
NMDA Receptor Ab Positive Plasma
Place your reservation now!
5. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
55
Disease State Plasma Availability
Infectious Diseases
Autoimmune/Non-Infectious Diseases
Our Capabilities
* Although inventory information is correct on date of publishing, many of
the materials are in high demand and stocks are limited. Custom sample
collections are possible where published inventory items are already sold.
6. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
6
INFECTIOUS DISEASES
High Demand selection from current inventory:
Disease Type
Product
Code
Quantitative results & other
markers tested
Volume available in stock
HCV Plasma Units SH259-4 Viral load and antibodies 1.7L
HBV/HCV Co-infected Units SH332-4 Positive for HBV and HCV Ab >1.5L
HAV SH265 HAV IgM 3.4L
HBsAg SH256
Hep B Core Total Ab HBsAb
Viral Load, Genotype, AD/AY
11.5L
Hep B Core IgM SH258 Hep B Core IgM 4.5L
Toxoplasma IgM SH275 Toxo IgM 2.8L
CMV IgM SH272 CMV IgM 2L
Parvovirus B19 SH331 Parvovirus B19 1.5L
ToRCH Negative
Please
Enquire
Single, multiple or full ToRCH
IgG/IgM Negative
>120L
Order your evaluation sample today
Minimum order 1 unit 100ml+
7. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
7
AUTOIMMUNE / NON-INFECTIOUS DISEASES
Selection from current inventory:
Disease Type Product Code
Quantitative results &
other Markers tested
Volume available in
stock (ml)
Anti-GBM SH336 Range of titres >10L
Bilirubin Positive Plasma SH294-3 Yes 2L
p-ANCA (MPO) SH152 Range of titres >20L
SAA SH127 Range of titres 20L
Thyroid Disease SH245 / SH244 Anti-Tg and Anti-TPO
Individual units or custom
pools >10L
Raised IgE High Titre SH234 Yes >10L
Lactate Dehydrogenase
Positive Plasma
SH102 Range of titres
>4L
Acetylcholine Receptor
Antibodies Pos Plasma
SH103 Yes 3L
Anti-Mitochondrial Ab SH431 Positive for M2 Ab >10L
CRP Elevated SH100 Range of titres >8L
Order you evaluation sample today
Minimum order size 100ml
9. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
99
Clinical Sample Availability
Infectious Disease SCIPAC Panels
Our Capabilities
* Although inventory information is correct on date of publishing, many of
the materials are in high demand and stocks are limited. Custom sample
collections are possible where published inventory items are already sold.
10. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
10
INFECTIOUS DISEASE SCIPAC PANELS
Panel specifications
Citrated plasma
Extensive donor demographics
Tested for HIV1 & 2 Abs, HBsAg, HCV Ab, HIV-1 / HBV / HCV PCR and Syphilis
Individual donors (no duplicates)
Donor consent
Code no. Description Type Characteristics
SHK315-4V
HIV-1 Plasma
Panel
Mixed Viral Load
102->600,000 Copies/ml
9 Positive members 1 negative 2x1ml per panel
SHK256-4V
HBsAg Plasma
Panel
Mixed Viral Load
149->600000000 IU/ml
9 Positive members 1 negative 2x1ml per panel
SHK256-4G
HBsAg Plasma
Panel
Genotype Panel
Genotypes A-F
9 Positive members 1 negative 2x1ml per panel
SHK259-4V
HCV Plasma
Panel
Mixed Viral Load
70->10000000 IU/ml
9 Positive members 1 negative 2x1ml per panel
SHK259-4G
HCV Plasma
Panel
Genotype Panel
Genotypes 1-6
8 Positive members 1 negative 1x1ml per panel
SHK266-4M
Syphilis Plasma
Panel
Mixed Titre
1:4 to 1:256 RPR
8 Positive members 1 negative 2x1ml per panel
11. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
11
Infectious Disease Autoimmune Inflammation / Allergy
CMV IgG / IgM HAMA PCT
H. Pylori Rheumatoid Factor IgE
HAV Anti-Tg CRP
HCV Anti-TPO
HBsAg Centromere Ab Biochemistry
HIV-1 Type 1 Diabetes Vitamin D
Lyme IgG Diagnosis D-Dimer
Malaria
HSV IgG / IgM Cardiac / Cardiovascular Endocrine
Malaria Troponin I/T Free T3 / T4
Rubella IgG Myoglobin PTH
Syphilis CK-MB TSH
Toxoplasma IgG / IgM NT-Pro BNP Testosterone
Parvovirus Triglycerides Progesterone
Chagas Cholesterol LH
Bilirubin Oestrogen
Organ Failure / Impairment
Cancer Renal Failure
CA125 Type 2 Diabetes
CA19-9 C-Peptide
CA15-3
AFP Pregnancy
CEA Pregnancy Serum / Plasma
Subject to Availability.
Please enquire to set up a prospective
collection.
Check out our product brochure for our
collection capabilities.
Not on this list? BBI Biobank can look to collect any
other marker of interest, just ask.OUR CAPABILITIES
Clinical Specimens
12. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
1212
Depleted Serum
An introduction to our standard products and custom services
* Although inventory information is correct on date of publishing, many of
the materials are in high demand and stocks are limited. Custom sample
collections are possible where published inventory items are already sold.
13. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
13
WHY USE OUR DEPLETED SERUMS?
“BBI have been manufacturing depleted serum for over 10 years. Our experience in this field has produced
a core range of high quality depleted serum products manufactured to ISO 9001 and ISO 13485 standards.”
Subject to lead time, volume requirement and specifications
Product Description Product Code Analyte
Typical Batch
Volume
Vitamin D SF504 Vitamin D, Vitamin D3+D2 3-60L
Immunoglobulins SF505 IgG, IgA, IgM, IgE IgD 3-15L
IgG SF142 IgG, IgA, IgM 12-25L
Steroid SF236
Progesterone, Testosterone, Cortisol,
Estradiol
12-25L
Hormones SF512
Progesterone, Testosterone, Cortisol,
Estradiol, FSH, LH, Prolactin
6L
TSH SF219
TSH (Optional Triglycerides and
Cholesterol)
6-9L
TBG SF125 TBG 12-30L
T3 / T4 SF231 T3, T4, Free T3, Free T4 3L
CRP SF100 CRP 3L
Testosterone SF518 Testosterone 3-60L
Not on this list? Check out our next slide for more
information on our custom depletion service.
14. Order today sales@bbisolutions.com
Int: +44 (0) 2920 767 499
USA: 1-800-423-8199
China: +852 2159 9666
14
CUSTOM DEPLETION SERVICE
“BBI offers a custom depletion service to our customers
when our standard product range does not meet their
requirements. Using our many years of experience,
working with our customers on custom depletion
products, BBI will work with you to scope, source and
manufacture the product(s) you need.”
Benefits:
Quick response time on project feasibility
Full and comprehensive scoping process
Raw materials required, sourced by BBI
Can be converted into a standard product and
potentially up-scaled* with long term commitment
Matrixes Considered for Custom Depletion
OTC Serum
Delipidated Defibrinated Plasma
*Subject to process used and specifications.
14